APREA THERAPEUTICS, INC. (APRE): $4.65

0.33 (+7.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add APRE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 494

in industry

Aprea Therapeutics Inc (APRE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering APRE.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $10 $6 $7.5 $4.97 50.91%

The Trend in the Analyst Price Target


Over the past 112 days, APRE's average price target has gone down $28.67.

Over the past 305 days, APRE's average upside potential has been 43.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-06-09 3 45 39 42.00 29.060 44.53%
2020-06-19 4 45 30 39.00 37.900 2.9%
2020-06-29 4 45 30 39.00 36.460 6.97%
2020-08-10 4 45 30 38.50 30.380 26.73%
2020-09-28 5 45 25 35.80 22.650 58.06%
2020-10-24 5 45 25 35.80 26.780 33.68%
2020-11-28 5 45 25 35.80 26.450 35.35%
2020-12-07 5 45 25 35.80 30.670 16.73%
2020-12-10 5 45 30 37.00 28.340 30.56%
2020-12-19 6 45 30 36.17 25.930 39.49%
2020-12-26 6 45 30 36.17 25.090 44.16%
2021-01-02 6 31 5 11.33 4.920 130.28%
2021-01-09 6 31 5 11.33 5.100 122.16%
2021-01-16 6 31 5 11.33 5.150 120%
2021-01-23 5 10 5 7.40 5.710 29.6%
2021-01-30 4 10 6 8.00 5.520 44.93%
2021-02-06 4 10 6 8.00 6.650 20.3%
2021-02-13 4 10 6 8.00 7.280 9.89%
2021-02-20 4 10 6 8.00 6.850 16.79%
2021-02-27 4 10 6 8.00 6.030 32.67%
2021-03-06 4 10 6 8.00 5.385 48.56%
2021-03-13 4 10 6 8.00 5.960 34.23%
2021-03-20 4 10 6 7.50 5.700 31.58%
2021-04-03 4 10 6 7.50 5.040 48.81%
2021-04-10 4 10 6 7.50 4.970 50.91%

APRE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.9 0 1 4 0 0 5

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • APRE has a higher average analyst price target than 14.72% of all US stocks.
  • APRE has a lower variance in analysts' estimates than 20.52% of stocks in the small market cap category.
  • APRE has a greater upside potential (average analyst target price relative to current price) than 77.55% of all US stocks.
  • The number of analysts covering the stock of APRE is greater than 34.8% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, STSA, LCI and LXRX are the three stocks most similar to Aprea Therapeutics Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for APRE? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7059 seconds.